Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. (SBFM) Stock Competitors & Peer Comparison
See (SBFM) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SBFM | $0.51 | +79.51% | 2.5M | -0.35 | -$1.44 | N/A |
| TAK | $16.57 | -0.21% | 52.4B | 43.63 | $0.38 | +3.73% |
| HLN | $9.17 | +2.34% | 40.7B | 18.34 | $0.50 | +2.16% |
| TEVA | $34.04 | -0.74% | 39.6B | 25.41 | $1.34 | N/A |
| VTRS | $16.50 | +0.12% | 19.2B | -55.00 | -$0.30 | +2.91% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| RGC | $27.71 | -3.04% | 13.7B | -2779.00 | -$0.01 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| RDY | $13.60 | -0.07% | 11.3B | 25.66 | $0.53 | +0.67% |
| ELAN | $19.92 | +0.33% | 10B | -39.89 | -$0.50 | N/A |
Stock Comparison
SBFM vs TAK Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TAK has a market cap of 52.4B. Regarding current trading prices, SBFM is priced at $0.51, while TAK trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TAK's P/E ratio is 43.63. In terms of profitability, SBFM's ROE is -0.26%, compared to TAK's ROE of +0.03%. Regarding short-term risk, SBFM is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TAK's competition here
SBFM vs HLN Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, HLN has a market cap of 40.7B. Regarding current trading prices, SBFM is priced at $0.51, while HLN trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas HLN's P/E ratio is 18.34. In terms of profitability, SBFM's ROE is -0.26%, compared to HLN's ROE of +0.17%. Regarding short-term risk, SBFM is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check HLN's competition here
SBFM vs TEVA Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TEVA has a market cap of 39.6B. Regarding current trading prices, SBFM is priced at $0.51, while TEVA trades at $34.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TEVA's P/E ratio is 25.41. In terms of profitability, SBFM's ROE is -0.26%, compared to TEVA's ROE of +0.21%. Regarding short-term risk, SBFM is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TEVA's competition here
SBFM vs VTRS Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, VTRS has a market cap of 19.2B. Regarding current trading prices, SBFM is priced at $0.51, while VTRS trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas VTRS's P/E ratio is -55.00. In terms of profitability, SBFM's ROE is -0.26%, compared to VTRS's ROE of -0.02%. Regarding short-term risk, SBFM is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check VTRS's competition here
SBFM vs ITCI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, SBFM is priced at $0.51, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ITCI's P/E ratio is -180.64. In terms of profitability, SBFM's ROE is -0.26%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, SBFM is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ITCI's competition here
SBFM vs RGC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, RGC has a market cap of 13.7B. Regarding current trading prices, SBFM is priced at $0.51, while RGC trades at $27.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas RGC's P/E ratio is -2779.00. In terms of profitability, SBFM's ROE is -0.26%, compared to RGC's ROE of -2.32%. Regarding short-term risk, SBFM is more volatile compared to RGC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check RGC's competition here
SBFM vs CTLT Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, SBFM is priced at $0.51, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CTLT's P/E ratio is -27.84. In terms of profitability, SBFM's ROE is -0.26%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, SBFM is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CTLT's competition here
SBFM vs RDY Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, RDY has a market cap of 11.3B. Regarding current trading prices, SBFM is priced at $0.51, while RDY trades at $13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas RDY's P/E ratio is 25.66. In terms of profitability, SBFM's ROE is -0.26%, compared to RDY's ROE of +0.12%. Regarding short-term risk, SBFM is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check RDY's competition here
SBFM vs ELAN Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ELAN has a market cap of 10B. Regarding current trading prices, SBFM is priced at $0.51, while ELAN trades at $19.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ELAN's P/E ratio is -39.89. In terms of profitability, SBFM's ROE is -0.26%, compared to ELAN's ROE of -0.04%. Regarding short-term risk, SBFM is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ELAN's competition here
SBFM vs LNTH Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, LNTH has a market cap of 6.1B. Regarding current trading prices, SBFM is priced at $0.51, while LNTH trades at $93.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas LNTH's P/E ratio is 22.23. In terms of profitability, SBFM's ROE is -0.26%, compared to LNTH's ROE of +0.24%. Regarding short-term risk, SBFM is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check LNTH's competition here
SBFM vs INDV Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, INDV has a market cap of 4.6B. Regarding current trading prices, SBFM is priced at $0.51, while INDV trades at $36.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas INDV's P/E ratio is 18.74. In terms of profitability, SBFM's ROE is -0.26%, compared to INDV's ROE of -1.42%. Regarding short-term risk, SBFM is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check INDV's competition here
SBFM vs AMRX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, AMRX has a market cap of 3.8B. Regarding current trading prices, SBFM is priced at $0.51, while AMRX trades at $11.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas AMRX's P/E ratio is 32.22. In terms of profitability, SBFM's ROE is -0.26%, compared to AMRX's ROE of -1.45%. Regarding short-term risk, SBFM is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check AMRX's competition here
SBFM vs SUPN Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, SBFM is priced at $0.51, while SUPN trades at $48.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas SUPN's P/E ratio is -94.76. In terms of profitability, SBFM's ROE is -0.26%, compared to SUPN's ROE of -0.03%. Regarding short-term risk, SBFM is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check SUPN's competition here
SBFM vs DCPH Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, SBFM is priced at $0.51, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas DCPH's P/E ratio is -11.58. In terms of profitability, SBFM's ROE is -0.26%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, SBFM is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check DCPH's competition here
SBFM vs AVDL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, SBFM is priced at $0.51, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, SBFM's ROE is -0.26%, compared to AVDL's ROE of -0.00%. Regarding short-term risk, SBFM is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check AVDL's competition here
SBFM vs HCM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, HCM has a market cap of 2.1B. Regarding current trading prices, SBFM is priced at $0.51, while HCM trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas HCM's P/E ratio is 4.51. In terms of profitability, SBFM's ROE is -0.26%, compared to HCM's ROE of +0.41%. Regarding short-term risk, SBFM is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check HCM's competition here
SBFM vs BHC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, BHC has a market cap of 2B. Regarding current trading prices, SBFM is priced at $0.51, while BHC trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas BHC's P/E ratio is -1.65. In terms of profitability, SBFM's ROE is -0.26%, compared to BHC's ROE of +1.21%. Regarding short-term risk, SBFM is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check BHC's competition here
SBFM vs EMBCV Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, SBFM is priced at $0.51, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas EMBCV's P/E ratio is N/A. In terms of profitability, SBFM's ROE is -0.26%, compared to EMBCV's ROE of -0.23%. Regarding short-term risk, SBFM is more volatile compared to EMBCV. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check EMBCV's competition here
SBFM vs DVAX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, SBFM is priced at $0.51, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas DVAX's P/E ratio is -41.89. In terms of profitability, SBFM's ROE is -0.26%, compared to DVAX's ROE of -0.08%. Regarding short-term risk, SBFM is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check DVAX's competition here
SBFM vs ANIP Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ANIP has a market cap of 1.8B. Regarding current trading prices, SBFM is priced at $0.51, while ANIP trades at $79.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ANIP's P/E ratio is 20.29. In terms of profitability, SBFM's ROE is -0.26%, compared to ANIP's ROE of +0.17%. Regarding short-term risk, SBFM is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ANIP's competition here
SBFM vs TARO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, SBFM is priced at $0.51, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TARO's P/E ratio is 30.05. In terms of profitability, SBFM's ROE is -0.26%, compared to TARO's ROE of +0.03%. Regarding short-term risk, SBFM is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TARO's competition here
SBFM vs PRGO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PRGO has a market cap of 1.5B. Regarding current trading prices, SBFM is priced at $0.51, while PRGO trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PRGO's P/E ratio is -0.83. In terms of profitability, SBFM's ROE is -0.26%, compared to PRGO's ROE of -0.51%. Regarding short-term risk, SBFM is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PRGO's competition here
SBFM vs PAHC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, SBFM is priced at $0.51, while PAHC trades at $34.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PAHC's P/E ratio is 14.67. In terms of profitability, SBFM's ROE is -0.26%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, SBFM is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PAHC's competition here
SBFM vs HROW Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, HROW has a market cap of 1.2B. Regarding current trading prices, SBFM is priced at $0.51, while HROW trades at $30.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas HROW's P/E ratio is -81.32. In terms of profitability, SBFM's ROE is -0.26%, compared to HROW's ROE of -0.34%. Regarding short-term risk, SBFM is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check HROW's competition here
SBFM vs COLL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, COLL has a market cap of 1.1B. Regarding current trading prices, SBFM is priced at $0.51, while COLL trades at $33.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas COLL's P/E ratio is 16.33. In terms of profitability, SBFM's ROE is -0.26%, compared to COLL's ROE of +0.27%. Regarding short-term risk, SBFM is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check COLL's competition here
SBFM vs ALVO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ALVO has a market cap of 1B. Regarding current trading prices, SBFM is priced at $0.51, while ALVO trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ALVO's P/E ratio is 32.50. In terms of profitability, SBFM's ROE is -0.26%, compared to ALVO's ROE of -0.12%. Regarding short-term risk, SBFM is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ALVO's competition here
SBFM vs CRON Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CRON has a market cap of 979M. Regarding current trading prices, SBFM is priced at $0.51, while CRON trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CRON's P/E ratio is -131.00. In terms of profitability, SBFM's ROE is -0.26%, compared to CRON's ROE of -0.00%. Regarding short-term risk, SBFM is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CRON's competition here
SBFM vs EVO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, EVO has a market cap of 973.2M. Regarding current trading prices, SBFM is priced at $0.51, while EVO trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas EVO's P/E ratio is -4.28. In terms of profitability, SBFM's ROE is -0.26%, compared to EVO's ROE of -0.24%. Regarding short-term risk, SBFM is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check EVO's competition here
SBFM vs PETQ Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, SBFM is priced at $0.51, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PETQ's P/E ratio is 83.73. In terms of profitability, SBFM's ROE is -0.26%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, SBFM is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PETQ's competition here
SBFM vs PCRX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PCRX has a market cap of 882.7M. Regarding current trading prices, SBFM is priced at $0.51, while PCRX trades at $22.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PCRX's P/E ratio is 172.62. In terms of profitability, SBFM's ROE is -0.26%, compared to PCRX's ROE of +0.01%. Regarding short-term risk, SBFM is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PCRX's competition here
SBFM vs AMPH Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, AMPH has a market cap of 758.4M. Regarding current trading prices, SBFM is priced at $0.51, while AMPH trades at $17.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas AMPH's P/E ratio is 10.36. In terms of profitability, SBFM's ROE is -0.26%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, SBFM is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check AMPH's competition here
SBFM vs TLRY Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TLRY has a market cap of 619.5M. Regarding current trading prices, SBFM is priced at $0.51, while TLRY trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TLRY's P/E ratio is -0.35. In terms of profitability, SBFM's ROE is -0.26%, compared to TLRY's ROE of -0.93%. Regarding short-term risk, SBFM is more volatile compared to TLRY. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TLRY's competition here
SBFM vs BDSI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, SBFM is priced at $0.51, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas BDSI's P/E ratio is 6.82. In terms of profitability, SBFM's ROE is -0.26%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, SBFM is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check BDSI's competition here
SBFM vs IRWD Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, IRWD has a market cap of 576.1M. Regarding current trading prices, SBFM is priced at $0.51, while IRWD trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas IRWD's P/E ratio is 5.65. In terms of profitability, SBFM's ROE is -0.26%, compared to IRWD's ROE of -0.39%. Regarding short-term risk, SBFM is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check IRWD's competition here
SBFM vs KMDA Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, KMDA has a market cap of 451.7M. Regarding current trading prices, SBFM is priced at $0.51, while KMDA trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas KMDA's P/E ratio is 22.37. In terms of profitability, SBFM's ROE is -0.26%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, SBFM is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check KMDA's competition here
SBFM vs EOLS Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, EOLS has a market cap of 432.7M. Regarding current trading prices, SBFM is priced at $0.51, while EOLS trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas EOLS's P/E ratio is -9.95. In terms of profitability, SBFM's ROE is -0.26%, compared to EOLS's ROE of +1.75%. Regarding short-term risk, SBFM is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check EOLS's competition here
SBFM vs CGC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CGC has a market cap of 418.3M. Regarding current trading prices, SBFM is priced at $0.51, while CGC trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CGC's P/E ratio is -0.72. In terms of profitability, SBFM's ROE is -0.26%, compared to CGC's ROE of -0.53%. Regarding short-term risk, SBFM is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CGC's competition here
SBFM vs AQST Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, AQST has a market cap of 410.6M. Regarding current trading prices, SBFM is priced at $0.51, while AQST trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas AQST's P/E ratio is -6.78. In terms of profitability, SBFM's ROE is -0.26%, compared to AQST's ROE of +1.91%. Regarding short-term risk, SBFM is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check AQST's competition here
SBFM vs SNDL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, SNDL has a market cap of 360.3M. Regarding current trading prices, SBFM is priced at $0.51, while SNDL trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas SNDL's P/E ratio is -46.33. In terms of profitability, SBFM's ROE is -0.26%, compared to SNDL's ROE of -0.01%. Regarding short-term risk, SBFM is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check SNDL's competition here
SBFM vs ORGO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ORGO has a market cap of 319.1M. Regarding current trading prices, SBFM is priced at $0.51, while ORGO trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ORGO's P/E ratio is -20.67. In terms of profitability, SBFM's ROE is -0.26%, compared to ORGO's ROE of -0.00%. Regarding short-term risk, SBFM is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ORGO's competition here
SBFM vs SIGA Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, SIGA has a market cap of 306.3M. Regarding current trading prices, SBFM is priced at $0.51, while SIGA trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas SIGA's P/E ratio is 15.25. In terms of profitability, SBFM's ROE is -0.26%, compared to SIGA's ROE of +0.11%. Regarding short-term risk, SBFM is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check SIGA's competition here
SBFM vs ALIM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, SBFM is priced at $0.51, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ALIM's P/E ratio is 5.28. In terms of profitability, SBFM's ROE is -0.26%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, SBFM is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ALIM's competition here
SBFM vs LNDC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, SBFM is priced at $0.51, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas LNDC's P/E ratio is -4.04. In terms of profitability, SBFM's ROE is -0.26%, compared to LNDC's ROE of -9.05%. Regarding short-term risk, SBFM is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check LNDC's competition here
SBFM vs TYHT Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, SBFM is priced at $0.51, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TYHT's P/E ratio is -1.61. In terms of profitability, SBFM's ROE is -0.26%, compared to TYHT's ROE of -0.65%. Regarding short-term risk, SBFM is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TYHT's competition here
SBFM vs TKNO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TKNO has a market cap of 194.1M. Regarding current trading prices, SBFM is priced at $0.51, while TKNO trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TKNO's P/E ratio is -11.68. In terms of profitability, SBFM's ROE is -0.26%, compared to TKNO's ROE of -0.24%. Regarding short-term risk, SBFM is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TKNO's competition here
SBFM vs ACB Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ACB has a market cap of 186M. Regarding current trading prices, SBFM is priced at $0.51, while ACB trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ACB's P/E ratio is -3.01. In terms of profitability, SBFM's ROE is -0.26%, compared to ACB's ROE of -0.08%. Regarding short-term risk, SBFM is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ACB's competition here
SBFM vs EMBC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, EMBC has a market cap of 179.8M. Regarding current trading prices, SBFM is priced at $0.51, while EMBC trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas EMBC's P/E ratio is 1.60. In terms of profitability, SBFM's ROE is -0.26%, compared to EMBC's ROE of -0.17%. Regarding short-term risk, SBFM is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check EMBC's competition here
SBFM vs REPH Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, SBFM is priced at $0.51, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas REPH's P/E ratio is -8.04. In terms of profitability, SBFM's ROE is -0.26%, compared to REPH's ROE of -0.22%. Regarding short-term risk, SBFM is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check REPH's competition here
SBFM vs DERM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, DERM has a market cap of 172M. Regarding current trading prices, SBFM is priced at $0.51, while DERM trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas DERM's P/E ratio is -16.89. In terms of profitability, SBFM's ROE is -0.26%, compared to DERM's ROE of -0.36%. Regarding short-term risk, SBFM is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check DERM's competition here
SBFM vs LFCR Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, LFCR has a market cap of 164.3M. Regarding current trading prices, SBFM is priced at $0.51, while LFCR trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas LFCR's P/E ratio is -3.45. In terms of profitability, SBFM's ROE is -0.26%, compared to LFCR's ROE of -1.47%. Regarding short-term risk, SBFM is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check LFCR's competition here
SBFM vs THTX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, SBFM is priced at $0.51, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas THTX's P/E ratio is -17.84. In terms of profitability, SBFM's ROE is -0.26%, compared to THTX's ROE of +0.47%. Regarding short-term risk, SBFM is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check THTX's competition here
SBFM vs ASRT Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ASRT has a market cap of 150.7M. Regarding current trading prices, SBFM is priced at $0.51, while ASRT trades at $23.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ASRT's P/E ratio is -4.20. In terms of profitability, SBFM's ROE is -0.26%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, SBFM is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ASRT's competition here
SBFM vs OGI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, OGI has a market cap of 143.8M. Regarding current trading prices, SBFM is priced at $0.51, while OGI trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas OGI's P/E ratio is -6.59. In terms of profitability, SBFM's ROE is -0.26%, compared to OGI's ROE of -0.07%. Regarding short-term risk, SBFM is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check OGI's competition here
SBFM vs CRDL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CRDL has a market cap of 143.2M. Regarding current trading prices, SBFM is priced at $0.51, while CRDL trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CRDL's P/E ratio is -4.57. In terms of profitability, SBFM's ROE is -0.26%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, SBFM is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CRDL's competition here
SBFM vs SCTL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, SBFM is priced at $0.51, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas SCTL's P/E ratio is -7.86. In terms of profitability, SBFM's ROE is -0.26%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, SBFM is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check SCTL's competition here
SBFM vs PROC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, SBFM is priced at $0.51, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PROC's P/E ratio is 1.53. In terms of profitability, SBFM's ROE is -0.26%, compared to PROC's ROE of -2.22%. Regarding short-term risk, SBFM is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PROC's competition here
SBFM vs OPTN Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, SBFM is priced at $0.51, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas OPTN's P/E ratio is -4.42. In terms of profitability, SBFM's ROE is -0.26%, compared to OPTN's ROE of +0.45%. Regarding short-term risk, SBFM is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check OPTN's competition here
SBFM vs ZOM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, SBFM is priced at $0.51, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ZOM's P/E ratio is -1.62. In terms of profitability, SBFM's ROE is -0.26%, compared to ZOM's ROE of -0.19%. Regarding short-term risk, SBFM is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ZOM's competition here
SBFM vs GRVI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, SBFM is priced at $0.51, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas GRVI's P/E ratio is 26.05. In terms of profitability, SBFM's ROE is -0.26%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, SBFM is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check GRVI's competition here
SBFM vs CPIX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CPIX has a market cap of 76.7M. Regarding current trading prices, SBFM is priced at $0.51, while CPIX trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CPIX's P/E ratio is -10.45. In terms of profitability, SBFM's ROE is -0.26%, compared to CPIX's ROE of -0.29%. Regarding short-term risk, SBFM is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CPIX's competition here
SBFM vs ALVOW Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ALVOW has a market cap of 74.3M. Regarding current trading prices, SBFM is priced at $0.51, while ALVOW trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ALVOW's P/E ratio is N/A. In terms of profitability, SBFM's ROE is -0.26%, compared to ALVOW's ROE of -0.12%. Regarding short-term risk, SBFM is more volatile compared to ALVOW. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ALVOW's competition here
SBFM vs ZYNE Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, SBFM is priced at $0.51, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, SBFM's ROE is -0.26%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, SBFM is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ZYNE's competition here
SBFM vs SSIC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, SBFM is priced at $0.51, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas SSIC's P/E ratio is 11.93. In terms of profitability, SBFM's ROE is -0.26%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, SBFM is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check SSIC's competition here
SBFM vs VLNS Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, SBFM is priced at $0.51, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas VLNS's P/E ratio is -1.03. In terms of profitability, SBFM's ROE is -0.26%, compared to VLNS's ROE of N/A. Regarding short-term risk, SBFM is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check VLNS's competition here
SBFM vs DRRX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, SBFM is priced at $0.51, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas DRRX's P/E ratio is -4.44. In terms of profitability, SBFM's ROE is -0.26%, compared to DRRX's ROE of +0.13%. Regarding short-term risk, SBFM is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check DRRX's competition here
SBFM vs BGM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, BGM has a market cap of 55.2M. Regarding current trading prices, SBFM is priced at $0.51, while BGM trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas BGM's P/E ratio is -0.95. In terms of profitability, SBFM's ROE is -0.26%, compared to BGM's ROE of -0.03%. Regarding short-term risk, SBFM is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check BGM's competition here
SBFM vs JUPW Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, SBFM is priced at $0.51, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas JUPW's P/E ratio is -2.41. In terms of profitability, SBFM's ROE is -0.26%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, SBFM is more volatile compared to JUPW. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check JUPW's competition here
SBFM vs INCR Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, INCR has a market cap of 46.5M. Regarding current trading prices, SBFM is priced at $0.51, while INCR trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas INCR's P/E ratio is -3.70. In terms of profitability, SBFM's ROE is -0.26%, compared to INCR's ROE of -0.09%. Regarding short-term risk, SBFM is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check INCR's competition here
SBFM vs ZYBT Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ZYBT has a market cap of 44.9M. Regarding current trading prices, SBFM is priced at $0.51, while ZYBT trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ZYBT's P/E ratio is -4.30. In terms of profitability, SBFM's ROE is -0.26%, compared to ZYBT's ROE of -0.26%. Regarding short-term risk, SBFM is more volatile compared to ZYBT. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ZYBT's competition here
SBFM vs IXHL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, IXHL has a market cap of 43.5M. Regarding current trading prices, SBFM is priced at $0.51, while IXHL trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas IXHL's P/E ratio is -0.17. In terms of profitability, SBFM's ROE is -0.26%, compared to IXHL's ROE of -1.99%. Regarding short-term risk, SBFM is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check IXHL's competition here
SBFM vs QLI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, SBFM is priced at $0.51, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas QLI's P/E ratio is -4.92. In terms of profitability, SBFM's ROE is -0.26%, compared to QLI's ROE of -0.16%. Regarding short-term risk, SBFM is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check QLI's competition here
SBFM vs SCYX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, SCYX has a market cap of 34.5M. Regarding current trading prices, SBFM is priced at $0.51, while SCYX trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas SCYX's P/E ratio is -1.43. In terms of profitability, SBFM's ROE is -0.26%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, SBFM is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check SCYX's competition here
SBFM vs HEXO Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, SBFM is priced at $0.51, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas HEXO's P/E ratio is -0.26. In terms of profitability, SBFM's ROE is -0.26%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, SBFM is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check HEXO's competition here
SBFM vs RMTI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, RMTI has a market cap of 30.8M. Regarding current trading prices, SBFM is priced at $0.51, while RMTI trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas RMTI's P/E ratio is -5.21. In terms of profitability, SBFM's ROE is -0.26%, compared to RMTI's ROE of -45.88%. Regarding short-term risk, SBFM is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check RMTI's competition here
SBFM vs QNTM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, QNTM has a market cap of 28.1M. Regarding current trading prices, SBFM is priced at $0.51, while QNTM trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas QNTM's P/E ratio is -0.81. In terms of profitability, SBFM's ROE is -0.26%, compared to QNTM's ROE of -6.22%. Regarding short-term risk, SBFM is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check QNTM's competition here
SBFM vs CYTH Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, SBFM is priced at $0.51, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CYTH's P/E ratio is -0.80. In terms of profitability, SBFM's ROE is -0.26%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, SBFM is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CYTH's competition here
SBFM vs TXMD Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TXMD has a market cap of 23.4M. Regarding current trading prices, SBFM is priced at $0.51, while TXMD trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TXMD's P/E ratio is 202.00. In terms of profitability, SBFM's ROE is -0.26%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, SBFM is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TXMD's competition here
SBFM vs EVOK Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, SBFM is priced at $0.51, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas EVOK's P/E ratio is -7.97. In terms of profitability, SBFM's ROE is -0.26%, compared to EVOK's ROE of -1.01%. Regarding short-term risk, SBFM is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check EVOK's competition here
SBFM vs AYTU Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, AYTU has a market cap of 17M. Regarding current trading prices, SBFM is priced at $0.51, while AYTU trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas AYTU's P/E ratio is -0.46. In terms of profitability, SBFM's ROE is -0.26%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, SBFM is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check AYTU's competition here
SBFM vs TLPH Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, TLPH has a market cap of 16.4M. Regarding current trading prices, SBFM is priced at $0.51, while TLPH trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas TLPH's P/E ratio is -2.34. In terms of profitability, SBFM's ROE is -0.26%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, SBFM is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check TLPH's competition here
SBFM vs ACRX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, SBFM is priced at $0.51, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ACRX's P/E ratio is -0.31. In terms of profitability, SBFM's ROE is -0.26%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, SBFM is more volatile compared to ACRX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ACRX's competition here
SBFM vs AGRX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, SBFM is priced at $0.51, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas AGRX's P/E ratio is -0.89. In terms of profitability, SBFM's ROE is -0.26%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, SBFM is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check AGRX's competition here
SBFM vs BFRI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, BFRI has a market cap of 9.5M. Regarding current trading prices, SBFM is priced at $0.51, while BFRI trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas BFRI's P/E ratio is -0.76. In terms of profitability, SBFM's ROE is -0.26%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, SBFM is more volatile compared to BFRI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check BFRI's competition here
SBFM vs COSM Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, COSM has a market cap of 8.9M. Regarding current trading prices, SBFM is priced at $0.51, while COSM trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas COSM's P/E ratio is -0.47. In terms of profitability, SBFM's ROE is -0.26%, compared to COSM's ROE of -0.82%. Regarding short-term risk, SBFM is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check COSM's competition here
SBFM vs NLTX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, SBFM is priced at $0.51, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas NLTX's P/E ratio is -0.28. In terms of profitability, SBFM's ROE is -0.26%, compared to NLTX's ROE of -0.38%. Regarding short-term risk, SBFM is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check NLTX's competition here
SBFM vs YCBD Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, YCBD has a market cap of 8M. Regarding current trading prices, SBFM is priced at $0.51, while YCBD trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas YCBD's P/E ratio is 1.27. In terms of profitability, SBFM's ROE is -0.26%, compared to YCBD's ROE of -0.38%. Regarding short-term risk, SBFM is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check YCBD's competition here
SBFM vs LCI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, SBFM is priced at $0.51, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas LCI's P/E ratio is -0.04. In terms of profitability, SBFM's ROE is -0.26%, compared to LCI's ROE of +1.66%. Regarding short-term risk, SBFM is more volatile compared to LCI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check LCI's competition here
SBFM vs BGXX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, BGXX has a market cap of 7.3M. Regarding current trading prices, SBFM is priced at $0.51, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas BGXX's P/E ratio is -0.76. In terms of profitability, SBFM's ROE is -0.26%, compared to BGXX's ROE of -1.16%. Regarding short-term risk, SBFM is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check BGXX's competition here
SBFM vs ADMP Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, SBFM is priced at $0.51, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ADMP's P/E ratio is -0.08. In terms of profitability, SBFM's ROE is -0.26%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, SBFM is more volatile compared to ADMP. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ADMP's competition here
SBFM vs EGRX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, EGRX has a market cap of 4.9M. Regarding current trading prices, SBFM is priced at $0.51, while EGRX trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas EGRX's P/E ratio is 5.36. In terms of profitability, SBFM's ROE is -0.26%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, SBFM is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check EGRX's competition here
SBFM vs MNK Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, SBFM is priced at $0.51, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas MNK's P/E ratio is -0.44. In terms of profitability, SBFM's ROE is -0.26%, compared to MNK's ROE of -0.26%. Regarding short-term risk, SBFM is more volatile compared to MNK. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check MNK's competition here
SBFM vs FLGC Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, SBFM is priced at $0.51, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas FLGC's P/E ratio is -0.19. In terms of profitability, SBFM's ROE is -0.26%, compared to FLGC's ROE of -0.08%. Regarding short-term risk, SBFM is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check FLGC's competition here
SBFM vs GHSI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, GHSI has a market cap of 4.2M. Regarding current trading prices, SBFM is priced at $0.51, while GHSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas GHSI's P/E ratio is -0.79. In terms of profitability, SBFM's ROE is -0.26%, compared to GHSI's ROE of +0.01%. Regarding short-term risk, SBFM is more volatile compared to GHSI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check GHSI's competition here
SBFM vs GELS Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, GELS has a market cap of 3.7M. Regarding current trading prices, SBFM is priced at $0.51, while GELS trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas GELS's P/E ratio is -0.78. In terms of profitability, SBFM's ROE is -0.26%, compared to GELS's ROE of -0.43%. Regarding short-term risk, SBFM is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check GELS's competition here
SBFM vs RDHL Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, RDHL has a market cap of 2.9M. Regarding current trading prices, SBFM is priced at $0.51, while RDHL trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas RDHL's P/E ratio is N/A. In terms of profitability, SBFM's ROE is -0.26%, compared to RDHL's ROE of +2.91%. Regarding short-term risk, SBFM is more volatile compared to RDHL. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check RDHL's competition here
SBFM vs PLXP Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, SBFM is priced at $0.51, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PLXP's P/E ratio is -0.22. In terms of profitability, SBFM's ROE is -0.26%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, SBFM is more volatile compared to PLXP. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PLXP's competition here
SBFM vs ATNX Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, SBFM is priced at $0.51, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas ATNX's P/E ratio is -0.02. In terms of profitability, SBFM's ROE is -0.26%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, SBFM is more volatile compared to ATNX. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check ATNX's competition here
SBFM vs CPHI Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, CPHI has a market cap of 2.3M. Regarding current trading prices, SBFM is priced at $0.51, while CPHI trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas CPHI's P/E ratio is -0.96. In terms of profitability, SBFM's ROE is -0.26%, compared to CPHI's ROE of -0.00%. Regarding short-term risk, SBFM is more volatile compared to CPHI. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check CPHI's competition here
SBFM vs PROCW Comparison May 2026
SBFM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFM stands at 2.5M. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, SBFM is priced at $0.51, while PROCW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFM currently has a P/E ratio of -0.35, whereas PROCW's P/E ratio is N/A. In terms of profitability, SBFM's ROE is -0.26%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, SBFM is more volatile compared to PROCW. This indicates potentially higher risk in terms of short-term price fluctuations for SBFM.Check PROCW's competition here